14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.16 $18.63 Thursday, 25th Apr 2024 ACAD stock ended at $16.31. This is 1.69% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.17% from a day low at $16.16 to a day high of $16.51.
90 days $16.16 $27.94
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Mar 26, 2021 $25.95 $26.30 $25.37 $25.86 1 385 345
Mar 25, 2021 $25.09 $26.20 $24.99 $26.02 1 498 112
Mar 24, 2021 $25.86 $26.18 $25.22 $25.34 1 524 242
Mar 23, 2021 $26.94 $26.94 $25.78 $25.88 2 522 086
Mar 22, 2021 $27.86 $28.31 $26.96 $27.00 1 499 402
Mar 19, 2021 $27.31 $27.98 $26.65 $27.75 2 853 311
Mar 18, 2021 $27.36 $27.89 $26.75 $27.05 1 755 095
Mar 17, 2021 $27.39 $28.07 $27.06 $27.55 2 352 083
Mar 16, 2021 $30.12 $30.16 $26.75 $27.34 4 488 604
Mar 15, 2021 $27.08 $30.11 $26.86 $29.99 4 501 347
Mar 12, 2021 $26.55 $27.30 $25.98 $27.04 2 758 606
Mar 11, 2021 $27.18 $27.58 $26.42 $26.75 4 961 080
Mar 10, 2021 $25.61 $28.87 $25.56 $26.89 11 656 777
Mar 09, 2021 $25.95 $26.25 $23.35 $25.02 23 890 496
Mar 08, 2021 $49.08 $49.23 $45.71 $45.78 1 164 739
Mar 05, 2021 $46.03 $49.25 $44.30 $48.98 1 717 903
Mar 04, 2021 $47.52 $48.16 $45.44 $45.82 1 182 453
Mar 03, 2021 $47.07 $48.10 $45.55 $47.44 1 614 376
Mar 02, 2021 $49.22 $49.75 $46.87 $46.94 723 522
Mar 01, 2021 $49.34 $49.91 $48.56 $49.56 811 902
Feb 26, 2021 $47.34 $49.37 $47.13 $48.97 988 343
Feb 25, 2021 $48.29 $50.13 $47.17 $47.31 1 129 416
Feb 24, 2021 $49.71 $50.40 $48.33 $48.69 996 236
Feb 23, 2021 $48.78 $50.61 $48.13 $49.74 917 091
Feb 22, 2021 $50.63 $52.12 $50.07 $50.18 652 632
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT